-
COVID-19: NICE updates guideline as Sanofi announces vaccine development
pharmatimes
March 31, 2020
As the number of deaths in the UK more than doubled over the weekend, The National Institute for Health and Care Excellence (NICE) has updated its rapid COVID-19 critical care guideline.
-
Novartis, life sciences firms collaborate with BMGF to fight against COVID-19 disease
pharmaceutical-business-review
March 31, 2020
Novartis and a consortium of life sciences companies have collaborated with Bill & Melinda Gates Foundation (BMGF) to advance the development, manufacture and delivery of vaccines, diagnostics and treatments for COVID-19.
-
Sanofi, Translate Bio to develop novel mRNA vaccine for COVID-19 disease
pharmaceutical-business-review
March 31, 2020
Sanofi’s vaccines global business unit Sanofi Pasteur has collaborated with Translate Bio for the development of a novel messenger RNA (mRNA) vaccine for COVID-19, the disease resulted due to the novel coronavirus SARS-CoV-2.
-
Experimental AI tool predicts which COVID-19 patients develop respiratory disease
worldpharmanews
March 31, 2020
An artificial intelligence tool accurately predicted which patients newly infected with the COVID-19 virus would go on to develop severe respiratory disease, a new study found.
-
Berkshire Medical Center Nurses Call for Universal N95 Masking for Frontline Staff and Outside Patient Triage Area in Face of High Risk of Coronavirus (COVID-19) Exposure
prnewswire
March 31, 2020
Registered nurses at Berkshire Medical Center represented by the Massachusetts Nurses Association are calling for stronger personal protective equipment (PPE) standards ...
-
Mylan Waives Marketing Exclusivity in US for Lopinavir/Ritonavir for COVID-19 Needs
americanpharmaceuticalreview
March 31, 2020
Mylan announced, in its ongoing effort to support patients and public health needs in the current circumstances surrounding the COVID-19 pandemic.
-
FDA Grants VERO Biotech Expanded Access Emergency Use of GENOSYL DS for COVID-19 Patients
americanpharmaceuticalreview
March 31, 2020
VERO Biotech announced the U.S. Food and Drug Administration (FDA) has granted "expanded access emergency use".
-
Advarra Offers Complimentary Transfer of IRB Oversight
contractpharma
March 31, 2020
Provides access to eRegulatory management software and a dedicated resource for guidance on emerging issues impacted by COVID-19.
-
Cobra Bio, Karolinska Inst. to Develop COVID-19 Vaccine
contractpharma
March 31, 2020
Cobra Biologics, an international contract development and manufacturing organization (CDMO) for biologics and pharmaceuticals, and the Karolinska Institutet ...
-
FDA Issues Emergency Approval for Anti-Malaria Drugs
contractpharma
March 31, 2020
HHS accepts donations of hydroxychloroquine sulfate, chloroquine phosphate as possible treatments for COVID-19 patients.